Who did the Blues acquire in the trade?
The Blues acquired forward Akil Thomas.
Hockey / NHL News
The St. Louis Blues have bolstered their roster by acquiring forward Akil Thomas from the Los Angeles Kings in a recent trade. This move aims to provide both Thomas and Alexandrov with fresh opportunities within new organizations.
The trade between the St. Louis Blues and the Los Angeles Kings sees Akil Thomas heading to St. Louis while Nikita Alexandrov joins the Kings. Thomas, a 25-year-old forward, has been playing with the Kings’ AHL affiliate, the Ontario Reign, where he has accumulated 13 points in 19 games this season. He also brings NHL experience, having played 32 games with the Kings. Alexandrov, also 25, was drafted by the Blues in 2019 and has played in 51 NHL games for the team. This trade provides both players with a chance to revitalize their careers in new environments. Thomas will report to the Springfield Thunderbirds, the Blues’ AHL affiliate. Both players are set to become free agents at the end of the 2025-26 season, adding further incentive to perform well in their new teams.
The Blues acquired forward Akil Thomas.
The Blues traded forward Nikita Alexandrov.
Akil Thomas will report to the Blues’ AHL affiliate, the Springfield Thunderbirds.
What do you think about this trade? Will Akil Thomas thrive with the Blues? Share this article with others who need to stay ahead of this trend!
This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.
All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.
This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.
Always do your own research (DYOR) before making any decisions based on the information presented.